Skip to main content
University of California San Francisco
UCSF School of Medicine | Department of Pediatrics UCSF Medical Center

The role of acuity of illness at presentation in early mortality in black children with acute myeloid leukemia.

  • Read more about The role of acuity of illness at presentation in early mortality in black children with acute myeloid leukemia.

Favorable outcomes after in utero transfusion in fetuses with alpha thalassemia major: a case series and review of the literature.

  • Read more about Favorable outcomes after in utero transfusion in fetuses with alpha thalassemia major: a case series and review of the literature.

Mortality Among Women with Sickle Cell Disease Admitted for Delivery, California 2004-2014.

  • Read more about Mortality Among Women with Sickle Cell Disease Admitted for Delivery, California 2004-2014.

Towards the Development of a Noninvasive Prenatal Test for Beta-Thalassemia: Utilization of Probe Capture Enrichment and Next Generation Sequencing.

  • Read more about Towards the Development of a Noninvasive Prenatal Test for Beta-Thalassemia: Utilization of Probe Capture Enrichment and Next Generation Sequencing.

Threshold Ferritin Values to Predict Control of Liver Iron Burden in Thalassemia.

  • Read more about Threshold Ferritin Values to Predict Control of Liver Iron Burden in Thalassemia.

Implications of Low Zinc and Copper Levels As Well As Altered Iron Trafficking Proteins on Oxidant Stress in Patients with Transfusion Dependant Thalassemia.

  • Read more about Implications of Low Zinc and Copper Levels As Well As Altered Iron Trafficking Proteins on Oxidant Stress in Patients with Transfusion Dependant Thalassemia.

Assessing Bone Quality Using Trabecular Bone Score in Patients with Hemoglobinopathies.

  • Read more about Assessing Bone Quality Using Trabecular Bone Score in Patients with Hemoglobinopathies.

The Genomic Landscape of Childhood and Adult Acute Erythroid Leukemia.

  • Read more about The Genomic Landscape of Childhood and Adult Acute Erythroid Leukemia.

RUNX1 Is a Candidate Transcriptional Effector in Juvenile Myelomonocytic Leukemia.

  • Read more about RUNX1 Is a Candidate Transcriptional Effector in Juvenile Myelomonocytic Leukemia.

Physician Factors Determining Treatment Decisions in Selecting Second Line Agents for Pediatric ITP.

  • Read more about Physician Factors Determining Treatment Decisions in Selecting Second Line Agents for Pediatric ITP.

Pagination

  • Previous page ‹‹
  • Page 107
  • Next page ››
Subscribe to

Pediatrics Home

MAKE A GIFT

© 2026 The Regents of the University of California. The University of California San Francisco  |  UCSF Department of Pediatrics                                                                                   Accessibility  Privacy Policy  Terms of Use  A-Z Website List